Serveur d'exploration sur la maladie de Parkinson

Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.

Neuroimaging and Cognition in Parkinson's Disease Dementia

Identifieur interne : 000631 ( Main/Exploration ); précédent : 000630; suivant : 000632

Neuroimaging and Cognition in Parkinson's Disease Dementia

Auteurs : Lisa C. Silbert ; Jeffrey Kaye

Source :

RBID : ISTEX:861CBB266F84BFBB5A0A88B6787C2F0CC5960CC3

English descriptors

Abstract

The prevalence of cognitive impairment and dementia in Parkinson's disease (PD) is high and can potentially occur as the result of multiple differing pathologies. Neuroimaging has provided evidence of decreased cortical volume, increased white matter diffusion changes, and decreased resting metabolic activity that appears to begin prior to the onset of dementia in PD patients. Cognitive impairment has been found to be associated with multiple neurotransmitter transmission deficiencies, including dopamine and acetylcholine, indicating a widespread neurotransmitter dysfunction in PD‐related dementia. Findings of increased Pittsburgh Compound B (PiB) binding in subjects with Lewy Body Disease (LBD) compared with Parkinson's disease and dementia (PDD) may explain phenotype differences in the spectrum of Dementia with Lewy Bodies (DLB), and show promise in guiding future therapeutic trials aimed at this disease. Advances in neuroimaging now allow for the detection of volumetric, pharmacologic, and pathological changes that may assist in the diagnosis and prediction of cognitive impairment in Parkinson's patients so that better evaluation of disease progression and treatment can be obtained.

Url:
DOI: 10.1111/j.1750-3639.2009.00368.x


Affiliations:


Links toward previous steps (curation, corpus...)


Le document en format XML

<record>
<TEI wicri:istexFullTextTei="biblStruct">
<teiHeader>
<fileDesc>
<titleStmt>
<title xml:lang="en">Neuroimaging and Cognition in Parkinson's Disease Dementia</title>
<author>
<name sortKey="Silbert, Lisa C" sort="Silbert, Lisa C" uniqKey="Silbert L" first="Lisa C." last="Silbert">Lisa C. Silbert</name>
</author>
<author>
<name sortKey="Kaye, Jeffrey" sort="Kaye, Jeffrey" uniqKey="Kaye J" first="Jeffrey" last="Kaye">Jeffrey Kaye</name>
</author>
</titleStmt>
<publicationStmt>
<idno type="wicri:source">ISTEX</idno>
<idno type="RBID">ISTEX:861CBB266F84BFBB5A0A88B6787C2F0CC5960CC3</idno>
<date when="2010" year="2010">2010</date>
<idno type="doi">10.1111/j.1750-3639.2009.00368.x</idno>
<idno type="url">https://api.istex.fr/document/861CBB266F84BFBB5A0A88B6787C2F0CC5960CC3/fulltext/pdf</idno>
<idno type="wicri:Area/Main/Corpus">000151</idno>
<idno type="wicri:Area/Main/Curation">000125</idno>
<idno type="wicri:Area/Main/Exploration">000631</idno>
</publicationStmt>
<sourceDesc>
<biblStruct>
<analytic>
<title level="a" type="main" xml:lang="en">Neuroimaging and Cognition in Parkinson's Disease Dementia</title>
<author>
<name sortKey="Silbert, Lisa C" sort="Silbert, Lisa C" uniqKey="Silbert L" first="Lisa C." last="Silbert">Lisa C. Silbert</name>
<affiliation>
<wicri:noCountry code="subField">Or</wicri:noCountry>
</affiliation>
</author>
<author>
<name sortKey="Kaye, Jeffrey" sort="Kaye, Jeffrey" uniqKey="Kaye J" first="Jeffrey" last="Kaye">Jeffrey Kaye</name>
<affiliation>
<wicri:noCountry code="subField">Or</wicri:noCountry>
</affiliation>
</author>
</analytic>
<monogr></monogr>
<series>
<title level="j">Brain Pathology</title>
<idno type="ISSN">1015-6305</idno>
<idno type="eISSN">1750-3639</idno>
<imprint>
<publisher>Blackwell Publishing Ltd</publisher>
<pubPlace>Oxford, UK</pubPlace>
<date type="published" when="2010-05">2010-05</date>
<biblScope unit="volume">20</biblScope>
<biblScope unit="issue">3</biblScope>
<biblScope unit="page" from="646">646</biblScope>
<biblScope unit="page" to="653">653</biblScope>
</imprint>
<idno type="ISSN">1015-6305</idno>
</series>
<idno type="istex">861CBB266F84BFBB5A0A88B6787C2F0CC5960CC3</idno>
<idno type="DOI">10.1111/j.1750-3639.2009.00368.x</idno>
<idno type="ArticleID">BPA368</idno>
</biblStruct>
</sourceDesc>
<seriesStmt>
<idno type="ISSN">1015-6305</idno>
</seriesStmt>
</fileDesc>
<profileDesc>
<textClass>
<keywords scheme="KwdEn" xml:lang="en">
<term>Cognition</term>
<term>Dementia</term>
<term>Neuroimaging</term>
<term>Parkinson's Disease</term>
<term>magnetic resonance imaging (MRI)</term>
</keywords>
</textClass>
<langUsage>
<language ident="en">en</language>
</langUsage>
</profileDesc>
</teiHeader>
<front>
<div type="abstract" xml:lang="en">The prevalence of cognitive impairment and dementia in Parkinson's disease (PD) is high and can potentially occur as the result of multiple differing pathologies. Neuroimaging has provided evidence of decreased cortical volume, increased white matter diffusion changes, and decreased resting metabolic activity that appears to begin prior to the onset of dementia in PD patients. Cognitive impairment has been found to be associated with multiple neurotransmitter transmission deficiencies, including dopamine and acetylcholine, indicating a widespread neurotransmitter dysfunction in PD‐related dementia. Findings of increased Pittsburgh Compound B (PiB) binding in subjects with Lewy Body Disease (LBD) compared with Parkinson's disease and dementia (PDD) may explain phenotype differences in the spectrum of Dementia with Lewy Bodies (DLB), and show promise in guiding future therapeutic trials aimed at this disease. Advances in neuroimaging now allow for the detection of volumetric, pharmacologic, and pathological changes that may assist in the diagnosis and prediction of cognitive impairment in Parkinson's patients so that better evaluation of disease progression and treatment can be obtained.</div>
</front>
</TEI>
<affiliations>
<list></list>
<tree>
<noCountry>
<name sortKey="Kaye, Jeffrey" sort="Kaye, Jeffrey" uniqKey="Kaye J" first="Jeffrey" last="Kaye">Jeffrey Kaye</name>
<name sortKey="Silbert, Lisa C" sort="Silbert, Lisa C" uniqKey="Silbert L" first="Lisa C." last="Silbert">Lisa C. Silbert</name>
</noCountry>
</tree>
</affiliations>
</record>

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Sante/explor/ParkinsonV1/Data/Main/Exploration
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000631 | SxmlIndent | more

Ou

HfdSelect -h $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd -nk 000631 | SxmlIndent | more

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Sante
   |area=    ParkinsonV1
   |flux=    Main
   |étape=   Exploration
   |type=    RBID
   |clé=     ISTEX:861CBB266F84BFBB5A0A88B6787C2F0CC5960CC3
   |texte=   Neuroimaging and Cognition in Parkinson's Disease Dementia
}}

Wicri

This area was generated with Dilib version V0.6.23.
Data generation: Sun Jul 3 18:06:51 2016. Site generation: Wed Mar 6 18:46:03 2024